2,180
Views
45
CrossRef citations to date
0
Altmetric
Report

Regulatory role of rpL3 in cell response to nucleolar stress induced by Act D in tumor cells lacking functional p53

, , , , , , , & show all
Pages 41-51 | Received 17 Aug 2015, Accepted 12 Nov 2015, Published online: 15 Jan 2016

References

  • Quin JE, Devlin JR, Cameron D, Hannan KM, Pearson RB, Hannan RD. Targeting the nucleolus for cancer intervention. Biochim Biophys Acta 2014; 1842:802-16; PMID:24389329; http://dx.doi.org/10.1016/j.bbadis.2013.12.009
  • Golomb L, Volarevic S, Oren M. p53 and ribosome biogenesis stress: the essentials. FEBS Lett 2014; 588:2571-9; PMID:24747423; http://dx.doi.org/10.1016/j.febslet.2014.04.014
  • Boulon S, Westman BJ, Hutten S, Boisvert FM, Lamond AI. The nucleolus under stress. Mol Cell 2010; 40:216-27; PMID:20965417; http://dx.doi.org/10.1016/j.molcel.2010.09.024
  • Henras AK, Plisson-Chastang C, O'Donohue MF, Chakraborty A, Gleizes PE. An overview of pre-ribosomal RNA processing in eukaryotes. Wiley Interdiscip Rev RNA 2015; 6:225-42; PMID:25346433; http://dx.doi.org/10.1002/wrna.1269
  • Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E, Rao PH, Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008; 456:971-5; PMID:19011615; http://dx.doi.org/10.1038/nature07449
  • Drygin D, Lin A, Bliesath J, Ho CB, O'Brien SE, Proffitt C, Omori M, Haddach M, Schwaebe MK, Siddiqui-Jain A, et al. Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Res 2011; 71:1418-30; PMID:21159662; http://dx.doi.org/10.1158/0008-5472.CAN-10-1728
  • Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, Cullinane C, Wall M, Cluse L, Drygin D, Anderes K, et al. Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012; 22:51-65; PMID:22789538; http://dx.doi.org/10.1016/j.ccr.2012.05.019
  • Chen CS, Ho DR, Chen FY, Chen CR, Ke YD, Su JG. AKT mediates actinomycin D-induced p53 expression. Oncotarget 2014; 5:693-703; PMID:24525337; http://dx.doi.org/10.18632/oncotarget.1328
  • Zhou X, Liao WJ, Liao JM, Liao P, Lu H. Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol 2015; 7:92-104; PMID:25735597; http://dx.doi.org/10.1093/jmcb/mjv014
  • Zhang Y, Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009; 16:369-77; PMID:19878869; http://dx.doi.org/10.1016/j.ccr.2009.09.024
  • Zhou X, Liao JM, Liao WJ, Lu H. Scission of the p53-MDM2 Loop by Ribosomal Proteins. Genes Cancer 2012; 3:298-310; PMID:23150763; http://dx.doi.org/10.1177/1947601912455200
  • Drygin D, O'Brien SE, Hannan RD, McArthur GA, Von Hoff DD. Targeting the nucleolus for cancer-specific activation of p53. Drug Discov Today 2014; 19:259-65; PMID:23993916; http://dx.doi.org/10.1016/j.drudis.2013.08.012
  • James A, Wang Y, Raje H, Rosby R, DiMario P. Nucleolar stress with and without p53. Nucleus 2014; 5:402-26; PMID:25482194; http://dx.doi.org/10.4161/nucl.32235
  • Jin YH, Yoo KJ, Lee YH, Lee SK. Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J Biol Chem 2000; 275:30256-63; PMID:10884382; http://dx.doi.org/10.1074/jbc.M001902200
  • Zhang Z, Wang H, Li M, Agrawal S, Chen X, Zhang R. MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem 2004; 279:16000-6; PMID:14761977; http://dx.doi.org/10.1074/jbc.M312264200
  • Esposito D, Crescenzi E, Sagar V, Loreni F, Russo A, Russo G. Human rpL3 plays a crucial role in cell response to nucleolar stress induced by 5-FU and L-OHP. Oncotarget 2014; 5:11737-51; PMID:25473889; http://dx.doi.org/10.18632/oncotarget.2591
  • Katagiri N, Kuroda T, Kishimoto H, Hayashi Y, Kumazawa T, Kimura K. The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription. Sci Rep 2015; 5:8903; PMID:25754892; http://dx.doi.org/10.1038/srep08903
  • Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010; 22:1003-12; PMID:20100570; http://dx.doi.org/10.1016/j.cellsig.2010.01.013
  • Coleman ML, Marshall CJ, Olson MF. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J 2003; 22:2036-46.
  • Ostrovsky O, Bengal E. The mitogen-activated protein kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent kinase inhibitor, p21WAF1 protein. J Biol Chem 2003; 278:21221-31; PMID:12637563; http://dx.doi.org/10.1074/jbc.M211357200
  • Karkhanis M, Park JI. Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells. Cell Signal 2015; 27:479-86; PMID:25595558; http://dx.doi.org/10.1016/j.cellsig.2015.01.005
  • Kressler D, Hurt E, Bassler J. Driving ribosome assembly. Biochim Biophys Acta 2010; 1803:673-83; PMID:19879902; http://dx.doi.org/10.1016/j.bbamcr.2009.10.009
  • Mayer C, Grummt I. Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 2006; 25:6384-91; PMID:17041624; http://dx.doi.org/10.1038/sj.onc.1209883
  • Rivlin N, Brosh R, Oren M, Rotter V. Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer 2011; 2:466-74; PMID:21779514; http://dx.doi.org/10.1177/1947601911408889
  • Russo A, Esposito D, Catillo M, Pietropaolo C, Crescenzi E, Russo G. Human rpL3 induces G(1)/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner. Cell Cycle 2013; 12:76-87; PMID:23255119; http://dx.doi.org/10.4161/cc.22963
  • Takada H, Kurisaki A. Emerging roles of nucleolar and ribosomal proteins in cancer, development, and aging. Cell Mol Life Sci 2015; 72(21):4015-25; PMID:26206377
  • Donati G, Montanaro L, Derenzini M. Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res 2012; 72:1602-7; PMID:22282659; http://dx.doi.org/10.1158/0008-5472.CAN-11-3992
  • Biswas B, Thakar A, Mohanti BK, Vishnubhatla S, Bakhshi S. Prognostic factors in head and neck Ewing sarcoma family of tumors. Laryngoscope 2015; 125:112-7; http://dx.doi.org/10.1002/lary.24985
  • Bursac S, Brdovcak MC, Pfannkuchen M, Orsolic I, Golomb L, Zhu Y, Katz C, Daftuar L, Grabusic K, Vukelic I, et al. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc Natl Acad Sci 2012; 109:20467-72; http://dx.doi.org/10.1073/pnas.1218535109
  • Hoshino M, Suzuki E, Miyake T, Sone M, Komatsu A, Nabeshima Y, Hama C. Neural expression of hikaru genki protein during embryonic and larval development of Drosophila melanogaster. Dev Genes Evol 1999; 209:1-9; PMID:9914413; http://dx.doi.org/10.1007/s004270050221
  • Ciccarelli C, Marampon F, Scoglio A, Mauro A, Giacinti C, De Cesaris P, Zani BM. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells. Mol Cancer 2005; 4:41; PMID:16351709; http://dx.doi.org/10.1186/1476-4598-4-41
  • Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death, apoptosis, autophagy and senescence. FEBS J 2010; 277:2-21; PMID:19843174; http://dx.doi.org/10.1111/j.1742-4658.2009.07366.x
  • Brozovic A, Osmak M. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett 2007; 251:1-16; PMID:17125914; http://dx.doi.org/10.1016/j.canlet.2006.10.007
  • She QB, Chen N, Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J Biol Chem 2000; 275:20444-9; PMID:10781582; http://dx.doi.org/10.1074/jbc.M001020200
  • Woessmann W, Chen X, Borkhardt A. Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines, Cancer Chemother Pharmacol 2002; 50:397-404; PMID:12439598; http://dx.doi.org/10.1007/s00280-002-0502-y
  • Russo A, Catillo M, Esposito D, Briata P, Pietropaolo C, Russo G. Autoregulatory circuit of human rpL3 expression requires hnRNP H1, NPM and KHSRP. Nucleic Acids Res 2011; 39:7576-85; PMID:21705779; http://dx.doi.org/10.1093/nar/gkr461
  • Todd DE, Densham RM, Molton SA, Balmanno K, Newson C, Weston CR, Garner AP, Scott L, Cook SJ. ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest. Oncogene 2004; 23:3284-95; PMID:14981547; http://dx.doi.org/10.1038/sj.onc.1207467
  • d'Emmanuele di Villa Bianca R, Mitidieri E, Esposito D, Donnarumma E, Russo A, Fusco F, Ianaro A, Mirone V, Cirino G, Russo G, Sorrentino R. Human cystathionine-b-synthase phosphorylation on serine 227 modulates hydrogen sulfide production in human urothelium. PLoS One 2015; 14:10-19; PMID: 26368121; http:// dx.doi.org/10.1371/journal.pone.0136859
  • Lavecchia A, Di Giovanni C, Cerchia C, Russo A, Russo G, Novellino E. Discovery of a novel small molecule inhibitor targeting the frataxin/ubiquitin interaction via structure-based virtual screening and bioassays. J Med Chem 2013; 56:2861-73; PMID: 23506486; http://dx.doi.org/10.1021/jm3017199
  • Russo A, Siciliano G, Catillo M, Giangrande C, Amoresano A, Pucci P, Pietropaolo C, Russo G. hnRNP H1 and intronic G runs in the splicing control of the human rpL3 gene. Biochim Biophys Acta 2010; 1799:419-28; PMID: 20100605; http://dx.doi.org/10.1016/j.bbagrm.2010.01.008
  • De Filippis D, Russo A, D'Amico A, Esposito G, Pietropaolo C, Cinelli M, Russo G, Iuvone T. Cannabinoids reduce granulomaassociated angiogenesis in rats by controlling transcription and expression of mast cell protease-5. Br J Pharmacol 2008; 154:1672-1679; PMID: 18552882; http://dx.doi.org/10.1038/bjp.2008.211
  • Maiolino S, Russo A, Pagliara V, Conte C, Ungaro F, Russo G, Quaglia F. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells. J Nanobiotechnol 2015; 13:29; PMID:25888948; http://dx.doi.org/10.1186/s12951-015-0088-2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.